Tj Langer

SVP, Cell Therapy Development & External Innovation at Turnstone Biologics

Tj Langer is the SVP, Cell Therapy Development & External Innovation at Turnstone Biologics. Previously, he was the CEO (Acquired By Turnstone) at Myst Therapeutics.

Links

Previous companies

Org chart

Tj Langer

SVP, Cell Therapy Development & External Innovation

Get started

Related people

Mark Singleton
GreenLight Biosciences
Myra Reinhardt
Xcenda
Fiona Killard-Lynch
NIBRT National Institute for Bioprocessing Research and Training
Wilfried Bakker
Batavia Biosciences
TK
Thomas Kean
Orthopaedic Research Society(ORS)

Tj Langer

SVP, Cell Therapy Development & External Innovation at Turnstone Biologics

Org chart

Related people

Mark Singleton

Myra Reinhardt

Fiona Killard-Lynch

Wilfried Bakker

Thomas Kean